{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T08:47:17Z","timestamp":1794732437291,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:00:00Z","timestamp":1587254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:00:00Z","timestamp":1587254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Glycogen storage disease type I (GSDI) is an inborn error of carbohydrate metabolism caused by mutations of either the G6PC gene (GSDIa) or the SLC37A4 gene (GSDIb). Glucose 6-phosphate (G6P) availability has been shown to modulate 11\u03b2-hydroxysteroid dehydrogenase type 1 (11\u03b2HSD1), an ER-bound enzyme catalyzing the local conversion of inactive cortisone into active cortisol. Adrenal cortex assessment has never been performed in GSDI. The aim of the current study was to evaluate the adrenal cortex hormones levels in GSDI patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Seventeen GSDI (10 GSDIa and 7 GSDIb) patients and thirty-four age and sex-matched controls were enrolled. Baseline adrenal cortex hormones and biochemical markers of metabolic control serum levels were analyzed. Low dose ACTH stimulation test was also performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Baseline cortisol serum levels were higher in GSDIa patients (<jats:italic>p<\/jats:italic>\u00a0=\u20090.042) and lower in GSDIb patients (<jats:italic>p<\/jats:italic>\u00a0=\u20090.041) than controls. GSDIa patients also showed higher peak cortisol response (<jats:italic>p<\/jats:italic>\u00a0=\u20090.000) and Cortisol AUC (<jats:italic>p<\/jats:italic>\u00a0=\u20090.029). In GSDIa patients, serum cholesterol (<jats:italic>p<\/jats:italic>\u00a0=\u20090.000), triglycerides (<jats:italic>p<\/jats:italic>\u2009=\u20090.000), lactate (<jats:italic>p<\/jats:italic>\u2009=\u20090.000) and uric acid (<jats:italic>p<\/jats:italic>\u00a0=\u20090.008) levels were higher and bicarbonate (<jats:italic>p<\/jats:italic>\u00a0=\u20090.000) levels were lower than controls. In GSDIb patients, serum cholesterol levels (<jats:italic>p<\/jats:italic>\u00a0=\u20090.016) were lower and lactate (<jats:italic>p<\/jats:italic>\u00a0=\u20090.000) and uric acid (<jats:italic>p<\/jats:italic>\u2009=\u20090.000) levels were higher than controls. Baseline cortisol serum levels directly correlated with cholesterol (\u03c1\u2009=\u20090.65, <jats:italic>p<\/jats:italic>\u00a0=\u20090.005) and triglycerides (\u03c1\u2009=\u20090.60, <jats:italic>p<\/jats:italic>\u00a0=\u20090.012) serum levels in GSDI patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present study showed impaired cortisol levels in GSDI patients, with opposite trend between GSDIa and GSDIb. The otherwise preserved adrenal cortex function suggests that this finding might be secondary to local deregulation rather than hypothalamo-pituitary-adrenal axis dysfunction in GSDI patients. We hypothesize that 11\u03b2HSD1 might represent the link between endocrine regulation and metabolic derangement in GSDI, constituting new potential therapeutic target in GSDI patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-01377-w","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T15:02:45Z","timestamp":1587308565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement"],"prefix":"10.1186","volume":"15","author":[{"given":"Alessandro","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Simeoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacarolina","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Ferrigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Della Casa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Strisciuglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,19]]},"reference":[{"issue":"11","key":"1377_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.128","volume":"16","author":"PS Kishnani","year":"2014","unstructured":"Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014;16(11):e1.","journal-title":"Genet Med"},{"issue":"37","key":"1377_CR2","doi-asserted-by":"publisher","first-page":"27030","DOI":"10.1074\/jbc.M704144200","volume":"282","author":"EA Walker","year":"2007","unstructured":"Walker EA, Ahmed A, Lavery GG, Tomlinson JW, Kim SY, Cooper MS, et al. 11beta-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis Function. J Biol Chem. 2007;282(37):27030\u20136.","journal-title":"J Biol Chem"},{"issue":"4","key":"1377_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/MOP.0b013e328305e439","volume":"20","author":"PC White","year":"2008","unstructured":"White PC, Rogoff D, McMillan DR. Physiological roles of 11 beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase. Curr Opin Pediatr. 2008;20(4):453\u20137.","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"1377_CR4","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1210\/endo.142.4.8114","volume":"142","author":"JR Seckl","year":"2001","unstructured":"Seckl JR, Walker BR. Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology. 2001;142(4):1371\u20136.","journal-title":"Endocrinology"},{"issue":"4","key":"1377_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1677\/JME-08-0156","volume":"42","author":"G B\u00e1nhegyi","year":"2009","unstructured":"B\u00e1nhegyi G, Csala M, Benedetti A. Hexose-6-phosphate dehydrogenase: linking endocrinology and metabolism in the endoplasmic reticulum. J Mol Endocrinol. 2009;42(4):283\u20139.","journal-title":"J Mol Endocrinol"},{"issue":"10","key":"1377_CR6","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1210\/en.2007-0593","volume":"148","author":"D Rogoff","year":"2007","unstructured":"Rogoff D, Ryder JW, Black K, Yan Z, Burgess SC, McMillan DR, et al. Abnormalities of glucose homeostasis and the hypothalamic-pituitary-adrenal axis in mice lacking hexose-6-phosphate dehydrogenase. Endocrinology. 2007;148(10):5072\u201380.","journal-title":"Endocrinology"},{"key":"1377_CR7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1046\/j.1365-2265.2003.01717.x","volume":"58","author":"HR Mundy","year":"2003","unstructured":"Mundy HR, Hindmarsh PC, Matthews DR, Leonard JV, Lee PJ. The regulation of growth in glycogen storage disease type 1. Clin Endocrinol. 2003;58:332\u20139.","journal-title":"Clin Endocrinol"},{"key":"1377_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/BF00441207","volume":"138","author":"DB Dunger","year":"1982","unstructured":"Dunger DB, Holder AT, Leonard JV, Okae J, Preece MA. Growth and Endocrine Changes in the Hepatic Glycogenoses. Eur J Pediatr. 1982;138:226\u201330.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"1377_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499\u2013502.","journal-title":"Clin Chem"},{"issue":"3","key":"1377_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jpeds.2006.11.056","volume":"150","author":"D Melis","year":"2007","unstructured":"Melis D, Pivonello R, Parenti G, Della Casa R, Salerno M, Lombardi G, et al. Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I. J Pediatr. 2007;150(3):300\u20135 305.e1.","journal-title":"J Pediatr"},{"issue":"6","key":"1377_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-2265.1995.tb02686.x","volume":"42","author":"PJ Lee","year":"1995","unstructured":"Lee PJ, Patel A, Hindmarsh PC, Mowat AP, Leonard JV. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism. Clin Endocrinol (Oxf). 1995;42(6):601\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1377_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1824-7288-40-30","volume":"40","author":"D Melis","year":"2014","unstructured":"Melis D, Della Casa R, Balivo F, Minopoli G, Rossi A, Salerno M, et al. Involvement of endocrine system in a patient affected by glycogen storage disease 1b: speculation on the role of autoimmunity. Ital J Pediatr. 2014;40(1):30.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"1377_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/npp.2015.215","volume":"41","author":"MG Arnett","year":"2016","unstructured":"Arnett MG, Muglia LM, Laryea G, Muglia LJ. Genetic Approaches to Hypothalamic-Pituitary-Adrenal Axis Regulation. Neuropsychopharmacology. 2016;41(1):245\u201360.","journal-title":"Neuropsychopharmacology"},{"key":"1377_CR14","first-page":"172","volume":"58","author":"M Vogesera","year":"2002","unstructured":"Vogesera M, Zachovalb R, Felbingerc TW, Jacoba K. Increased Ratio of Serum Cortisol to Cortisone in Acute-Phase Response. Horm Res. 2002;58:172\u20135.","journal-title":"Horm Res"},{"issue":"Suppl 1","key":"1377_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000314319","volume":"92","author":"R Pivonello","year":"2010","unstructured":"Pivonello R, De Leo M, Vitale P, Cozzolino A, Simeoli C, De Martino MC, et al. Pathophysiology of diabetes mellitus in Cushing\u2019s syndrome. Neuroendocrinology. 2010;92(Suppl 1):77\u201381.","journal-title":"Neuroendocrinology"},{"issue":"1\u20132","key":"1377_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mce.2003.11.015","volume":"215","author":"DJ Wake","year":"2004","unstructured":"Wake DJ, Walker BR. 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Mol Cell Endocrinol. 2004;215(1\u20132):45\u201354.","journal-title":"Mol Cell Endocrinol"},{"issue":"13\u201314","key":"1377_CR17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.drudis.2007.06.001","volume":"12","author":"M Wamil","year":"2007","unstructured":"Wamil M, Seckl JR. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target. Drug Discov Today. 2007;12(13\u201314):504\u201320.","journal-title":"Drug Discov Today"},{"issue":"4","key":"1377_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4254\/wjh.v4.i4.129","volume":"4","author":"I Czegle","year":"2012","unstructured":"Czegle I, Csala M, Mandl J, Benedetti A, Kar\u00e1di I, B\u00e1nhegyi G. G6PT-H6PDH-11\u03b2HSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome. World J Hepatol. 2012;4(4):129\u201338.","journal-title":"World J Hepatol"},{"issue":"5549","key":"1377_CR19","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1126\/science.1066285","volume":"294","author":"H Masuzaki","year":"2001","unstructured":"Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science. 2001;294(5549):2166\u201370.","journal-title":"Science"},{"issue":"26","key":"1377_CR20","doi-asserted-by":"publisher","first-page":"14924","DOI":"10.1073\/pnas.94.26.14924","volume":"94","author":"Y Kotelevtsev","year":"1997","unstructured":"Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, et al. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A. 1997;94(26):14924\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1377_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1530\/JME-12-0223","volume":"50","author":"H Du","year":"2013","unstructured":"Du H, Liu L, Wang Y, Nakagawa Y, Lyzlov A, Lutfy K, et al. Specific reduction of G6PT may contribute to downregulation of hepatic 11\u03b2-HSD1 in diabetic mice. J Mol Endocrinol. 2013;50(2):167\u201378.","journal-title":"J Mol Endocrinol"},{"issue":"6","key":"1377_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1517\/13543770902967658","volume":"19","author":"CD Boyle","year":"2009","unstructured":"Boyle CD, Kowalski TJ. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents. Expert Opin Ther Pat. 2009;19(6):801\u201325.","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"1377_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.metabol.2012.05.002","volume":"62","author":"P Anagnostis","year":"2013","unstructured":"Anagnostis P, Katsiki N, Adamidou F, Athyros VG, Karagiannis A, Kita M, et al. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders? Metabolism. 2013;62(1):21\u201333.","journal-title":"Metabolism"},{"key":"1377_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13023-015-0301-2","volume":"10","author":"D Melis","year":"2015","unstructured":"Melis D, Rossi A, Pivonello R, Salerno M, Balivo F, Spadarella S, et al. Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. Orphanet J Rare Dis. 2015;10:91.","journal-title":"Orphanet J Rare Dis"},{"key":"1377_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mce.2013.04.014","volume":"379","author":"WL Miller","year":"2013","unstructured":"Miller WL. Steroid hormone synthesis in mitochondria. Mol Cell Endocrinol. 2013;379:62\u201373.","journal-title":"Mol Cell Endocrinol"},{"key":"1377_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1194\/jlr.R009548","volume":"52","author":"FD Porter","year":"2011","unstructured":"Porter FD, Herman GE. Malformation syndromes caused by disorders of cholesterol synthesis. J. Lipid Res. 2011;52:6\u201334.","journal-title":"J. Lipid Res."},{"issue":"Suppl 1","key":"1377_CR27","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1007\/s00431-002-1007-8","volume":"161","author":"RH Bandsma","year":"2002","unstructured":"Bandsma RH, Smit GP, Kuipers F. Disturbed lipid metabolism in glycogen storage disease type 1. Eur J Pediatr. 2002;161(Suppl 1):S65\u20139.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"1377_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s10545-018-0149-4","volume":"41","author":"A Rossi","year":"2018","unstructured":"Rossi A, Ruoppolo M, Formisano P, Villani G, Albano L, Gallo G, et al. Insulin-resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria? J Inherit Metab Dis. 2018;41(6):985\u201395.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"1377_CR29","first-page":"1960","volume":"80","author":"R Hume","year":"1995","unstructured":"Hume R, Voice M, Pazouki S, Giunti R, Benedetti A, Burchell A. The human adrenal microsomal glucose-6-phosphatase system. J Clin Endocrinol Metab. 1995;80(6):1960\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"1377_CR30","doi-asserted-by":"publisher","first-page":"S227","DOI":"10.1007\/s10545-008-0810-4","volume":"31","author":"D Melis","year":"2008","unstructured":"Melis D, Balivo F, Della Casa R, Romano A, Taurisano R, Capaldo B, et al. Myasthenia gravis in a patient affected by glycogen storage disease type Ib: a further manifestation of an increased risk for autoimmune disorders? J Inherit Metab Dis. 2008;31(Suppl 2):S227\u201331.","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"1377_CR31","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1210\/en.2016-1118","volume":"157","author":"AE Coutinho","year":"2016","unstructured":"Coutinho AE, Kipari TM, Zhang Z, Esteves CL, Lucas CD, Gilmour JS, et al. 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 Is Expressed in Neutrophils and Restrains an Inflammatory Response in Male Mice. Endocrinology. 2016;157(7):2928\u201336. 4.","journal-title":"Endocrinology"},{"issue":"1","key":"1377_CR32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1210\/en.2011-1398","volume":"153","author":"AE Coutinho","year":"2012","unstructured":"Coutinho AE, Gray M, Brownstein DG, Salter DM, Sawatzky DA, Clay S, et al. 11\u03b2-Hydroxysteroid dehydrogenase type 1, but not type 2, deficiency worsens acute inflammation and experimental arthritis in mice. Endocrinology. 2012;153(1):234\u201340.","journal-title":"Endocrinology"},{"key":"1377_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jsbmb.2013.02.002","volume":"137","author":"KE Chapman","year":"2013","unstructured":"Chapman KE, Coutinho AE, Zhang Z, Kipari T, Savill JS, Seckl JR. Changing glucocorticoid action: 11\u03b2-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation. J Steroid Biochem Mol Biol. 2013;137:82\u201392.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1\u20132","key":"1377_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.mce.2008.09.031","volume":"301","author":"KE Chapman","year":"2009","unstructured":"Chapman KE, Coutinho AE, Gray M, Gilmour JS, Savill JS, Seckl JR. The role and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in the inflammatory response. Mol Cell Endocrinol. 2009;301(1\u20132):123\u201331.","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"1377_CR35","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/stem.140490","volume":"14","author":"JD Ashwell","year":"1996","unstructured":"Ashwell JD, King LB, Vacchio MS. Cross-talk between the T cell antigen receptor and the glucocorticoid receptor regulates thymocyte development. Stem Cells. 1996;14(5):490\u2013500.","journal-title":"Stem Cells"},{"issue":"3","key":"1377_CR36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nm.3085","volume":"19","author":"H Nie","year":"2013","unstructured":"Nie H, Zheng Y, Li R, Guo TB, He D, Fang L, et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-\u03b1 in rheumatoid arthritis. Nat Med. 2013;19(3):322\u20138.","journal-title":"Nat Med"},{"issue":"4\u20135","key":"1377_CR37","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.imbio.2017.10.010","volume":"223","author":"E Ugor","year":"2018","unstructured":"Ugor E, Prenek L, Pap R, Berta G, Ernszt D, Najbauer J, et al. Glucocorticoid hormone treatment enhances the cytokine production of regulatory T cells by upregulation of Foxp3 expression. Immunobiology. 2018;223(4\u20135):422\u201331.","journal-title":"Immunobiology"},{"issue":"2","key":"1377_CR38","doi-asserted-by":"publisher","first-page":"E181","DOI":"10.1073\/pnas.1617115114","volume":"114","author":"JB Engler","year":"2017","unstructured":"Engler JB, Kursawe N, Solano ME, Patas K, Wehrmann S, Heckmann N, et al. Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy. Proc Natl Acad Sci U S A. 2017;114(2):E181\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1377_CR39","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.4049\/jimmunol.1601946","volume":"198","author":"D Melis","year":"2017","unstructured":"Melis D, Carbone F, Minopoli G, La Rocca C, Perna F, De Rosa V, et al. Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function. J Immunol. 2017;198(10):3803\u20138.","journal-title":"J Immunol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01377-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01377-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01377-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T23:26:01Z","timestamp":1618788361000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01377-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,19]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1377"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01377-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,19]]},"assertion":[{"value":"2 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and approved by The the Medical Ethics Committee of the University of Naples \u201cFederico II\u201d (n. 151\/05). All studies were performed after informed consent was obtained from adult subjects or the infants\u2019 parents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}